Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 4,126 shares at $148.71 ($614K) on 2021-08-04, disclosed to the SEC on 2021-08-06.
Open-market sale of $614k NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.71 | 2,063 | $307K | 50.0% |
| 2 | $148.71 | 2,063 | $307K | 50.0% |
| Total | $148.71 avg | 4,126 | $614K | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |